Skip to main content
Log in

FLT3 mutations in patients with childhood acute lymphoblastic leukemia (ALL)

  • Letter to the Editor
  • Published:
Medical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Armstrong SA, Mabon ME, Silverman LB, Li A, Gribben JG, Fox EA, Sallan SE, Korsmeyer SJ. FLT3 mutations in childhood acute lymphoblastic leukemia. Blood. 2004;103:3544–6.

    Article  PubMed  CAS  Google Scholar 

  2. Gilliland DG, Griffin JD. The roles of FLT3 in hematopoiesis and leukemia. Blood. 2002;100:1532–42.

    Article  PubMed  CAS  Google Scholar 

  3. Taketani T, Taki T, Sugita K, Furuichi Y, Ishii E, Hanada R, Tsuchida M, Sugita K, Ida K, Hayashi Y. FLT3 mutations in the activation loop of tyrosine kinase domain are frequently found in infant ALL with MLL rearrangements and pediatric ALL with hyperdiploidy. Blood. 2004;103:1085–8.

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

The authors declare no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Julhash U. Kazi.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (PDF 19 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kabir, N.N., Rönnstrand, L. & Kazi, J.U. FLT3 mutations in patients with childhood acute lymphoblastic leukemia (ALL). Med Oncol 30, 462 (2013). https://doi.org/10.1007/s12032-013-0462-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12032-013-0462-6

Keywords

Navigation